Dana-Farber Cancer Institute, Massachusetts General Hospital, National Institutes of Health, University of Pennsylvania other research news

Four papers in The New England Journal of Medicine presented data on the usefulness of genetic testing for BRCA1 and BRCA2 in determining risk of breast cancer.

NIH researchers identified BRCA1 or BRCA2 mutations

Read the full 340 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE